Lan et al. reported more predominant Grem1 expression levels in myCAFs than in iCAFs, and in vivo loss of Grem1 within tumor cells reduced the amount of myCAFs, without affecting iCAF or apCAFs. The gene discussed is GREM1; the disease is neoplasm.